593 related articles for article (PubMed ID: 27138074)
1. Neuroimaging for diagnosing dementia with Lewy bodies: What is the best neuroimaging technique in discriminating dementia with Lewy bodies from Alzheimer's disease?
Shimizu S; Kanetaka H; Hirao K; Fukasawa R; Namioka N; Hatanaka H; Hirose D; Umahara T; Sakurai H; Hanyu H
Geriatr Gerontol Int; 2017 May; 17(5):819-824. PubMed ID: 27138074
[TBL] [Abstract][Full Text] [Related]
2. Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer's disease.
Shimizu S; Hirao K; Kanetaka H; Namioka N; Hatanaka H; Hirose D; Fukasawa R; Umahara T; Sakurai H; Hanyu H
Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):184-192. PubMed ID: 26233438
[TBL] [Abstract][Full Text] [Related]
3. Comparison of (123)I-MIBG myocardial scintigraphy, brain perfusion SPECT, and voxel-based MRI morphometry for distinguishing between dementia with Lewy bodies and Alzheimer's disease.
Inui Y; Toyama H; Manabe Y; Sarai M; Iwata N
Ann Nucl Med; 2014 Oct; 28(8):796-804. PubMed ID: 24986482
[TBL] [Abstract][Full Text] [Related]
4. The usefulness of combined brain perfusion single-photon emission computed tomography, Dopamine-transporter single-photon emission computed tomography, and
Kobayashi S; Makino K; Hatakeyama S; Ishii T; Tateno M; Iwamoto T; Tsujino H; Kawasaki K; Mikuni K; Ukai W; Murayama T; Hashimoto E; Utsumi K; Kawanishi C
Psychogeriatrics; 2017 Jul; 17(4):247-255. PubMed ID: 28130808
[TBL] [Abstract][Full Text] [Related]
5. (123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and (123) I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study.
Tiraboschi P; Corso A; Guerra UP; Nobili F; Piccardo A; Calcagni ML; Volterrani D; Cecchin D; Tettamanti M; Antelmi L; Vidale S; Sacco L; Merello M; Stefanini S; Micheli A; Vai P; Capitanio S; Gabanelli SV; Riva R; Pinto P; Biffi AM; Muscio C;
Ann Neurol; 2016 Sep; 80(3):368-78. PubMed ID: 27398636
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study.
McKeith I; O'Brien J; Walker Z; Tatsch K; Booij J; Darcourt J; Padovani A; Giubbini R; Bonuccelli U; Volterrani D; Holmes C; Kemp P; Tabet N; Meyer I; Reininger C;
Lancet Neurol; 2007 Apr; 6(4):305-13. PubMed ID: 17362834
[TBL] [Abstract][Full Text] [Related]
7. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies.
O'Brien JT; Colloby S; Fenwick J; Williams ED; Firbank M; Burn D; Aarsland D; McKeith IG
Arch Neurol; 2004 Jun; 61(6):919-25. PubMed ID: 15210531
[TBL] [Abstract][Full Text] [Related]
8. [123I]N-ω-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl)nortropane single-photon emission computed tomography brain imaging in the diagnosis of dementia with Lewy bodies.
Walker Z; Cummings JL
Alzheimers Dement; 2012 Jan; 8(1):74-83. PubMed ID: 22024052
[TBL] [Abstract][Full Text] [Related]
9. Comparative value of brain perfusion SPECT and [(123)I]MIBG myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer's disease.
Hanyu H; Shimizu S; Hirao K; Kanetaka H; Iwamoto T; Chikamori T; Usui Y; Yamashina A; Koizumi K; Abe K
Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):248-53. PubMed ID: 16328506
[TBL] [Abstract][Full Text] [Related]
10. A comparison of 99mTc-exametazime and 123I-FP-CIT SPECT imaging in the differential diagnosis of Alzheimer's disease and dementia with Lewy bodies.
Colloby SJ; Firbank MJ; Pakrasi S; Lloyd JJ; Driver I; McKeith IG; Williams ED; O'Brien JT
Int Psychogeriatr; 2008 Dec; 20(6):1124-40. PubMed ID: 18752700
[TBL] [Abstract][Full Text] [Related]
11. Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies.
McCleery J; Morgan S; Bradley KM; Noel-Storr AH; Ansorge O; Hyde C
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010633. PubMed ID: 25632881
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic imaging of dementia with Lewy bodies by susceptibility-weighted imaging of nigrosomes versus striatal dopamine transporter single-photon emission computed tomography: a retrospective observational study.
Kamagata K; Nakatsuka T; Sakakibara R; Tsuyusaki Y; Takamura T; Sato K; Suzuki M; Hori M; Kumamaru KK; Inaoka T; Aoki S; Terada H
Neuroradiology; 2017 Jan; 59(1):89-98. PubMed ID: 28035426
[TBL] [Abstract][Full Text] [Related]
13. The value of multimodal imaging with
Miyagawa T; Przybelski SA; Maltais D; Min HK; Jordan L; Lesnick TG; Chen Q; Graff-Radford J; Jones D; Savica R; Knopman D; Petersen R; Kremers WK; Forsberg LK; Fields JA; Ferman TJ; Allen L; Parisi J; Reichard RR; Murray M; Dickson D; Boeve BF; Kantarci K; Lowe VJ
Neurobiol Aging; 2021 Mar; 99():11-18. PubMed ID: 33422890
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of frontotemporal dementia from dementia with Lewy bodies using FP-CIT SPECT.
Morgan S; Kemp P; Booij J; Costa DC; Padayachee S; Lee L; Barber C; Carter J; Walker Z
J Neurol Neurosurg Psychiatry; 2012 Nov; 83(11):1063-70. PubMed ID: 22869921
[TBL] [Abstract][Full Text] [Related]
15. Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy.
Walker Z; Jaros E; Walker RW; Lee L; Costa DC; Livingston G; Ince PG; Perry R; McKeith I; Katona CL
J Neurol Neurosurg Psychiatry; 2007 Nov; 78(11):1176-81. PubMed ID: 17353255
[TBL] [Abstract][Full Text] [Related]
16. Serotonergic deficits in dementia with Lewy bodies with concomitant Alzheimer's disease pathology: An
van der Zande JJ; Joling M; Happach IG; Vriend C; Scheltens P; Booij J; Lemstra AW
Neuroimage Clin; 2020; 25():102062. PubMed ID: 31790878
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of dementia with Lewy bodies from Alzheimer's disease using Mini-Mental State Examination and brain perfusion SPECT.
Hanyu H; Shimizu S; Hirao K; Kanetaka H; Sakurai H; Iwamoto T; Koizumi K; Abe K
J Neurol Sci; 2006 Dec; 250(1-2):97-102. PubMed ID: 17005204
[TBL] [Abstract][Full Text] [Related]
18. Value of (99m)Tc-ECD SPET for the diagnosis of dementia with Lewy bodies.
Pasquier J; Michel BF; Brenot-Rossi I; Hassan-Sebbag N; Sauvan R; Gastaut JL
Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1342-8. PubMed ID: 12271417
[TBL] [Abstract][Full Text] [Related]
19. Validation of the cingulate island sign with optimized ratios for discriminating dementia with Lewy bodies from Alzheimer's disease using brain perfusion SPECT.
Imabayashi E; Soma T; Sone D; Tsukamoto T; Kimura Y; Sato N; Murata M; Matsuda H
Ann Nucl Med; 2017 Aug; 31(7):536-543. PubMed ID: 28547521
[TBL] [Abstract][Full Text] [Related]
20. [DaT-SCAN SPECT in the differential diagnosis of dementia with Lewy bodies and Alzheimer's disease].
Vaamonde-Gamo J; Flores-Barragán JM; Ibáñez R; Gudín M; Hernández A
Rev Neurol; 2005 Sep 1-15; 41(5):276-9. PubMed ID: 16138284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
